Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Stathmin 1: a novel therapeutic target for anticancer activity.

Rana S, Maples PB, Senzer N, Nemunaitis J.

Expert Rev Anticancer Ther. 2008 Sep;8(9):1461-70. doi: 10.1586/14737140.8.9.1461. Review.

PMID:
18759697
2.

Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy.

Mistry SJ, Atweh GF.

Mt Sinai J Med. 2002 Oct;69(5):299-304. Review.

PMID:
12415323
3.

Upregulated Op18/stathmin activity causes chromosomal instability through a mechanism that evades the spindle assembly checkpoint.

Holmfeldt P, Sellin ME, Gullberg M.

Exp Cell Res. 2010 Jul 15;316(12):2017-26. doi: 10.1016/j.yexcr.2010.04.008. Epub 2010 Apr 25.

PMID:
20399773
4.

The role of stathmin in the regulation of the cell cycle.

Rubin CI, Atweh GF.

J Cell Biochem. 2004 Oct 1;93(2):242-50. Review.

PMID:
15368352
5.

Effects of stathmin inhibition on the mitotic spindle.

Iancu C, Mistry SJ, Arkin S, Wallenstein S, Atweh GF.

J Cell Sci. 2001 Mar;114(Pt 5):909-16.

6.

Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis.

Larsson N, Marklund U, Gradin HM, Brattsand G, Gullberg M.

Mol Cell Biol. 1997 Sep;17(9):5530-9.

7.

Stathmin 1 is a potential novel oncogene in melanoma.

Chen J, Abi-Daoud M, Wang A, Yang X, Zhang X, Feilotter HE, Tron VA.

Oncogene. 2013 Mar 7;32(10):1330-7. doi: 10.1038/onc.2012.141. Epub 2012 Jun 4.

PMID:
22665054
8.

Stathmin expression is a feature of proliferating cells of most, if not all, cell lineages.

Rowlands DC, Williams A, Jones NA, Guest SS, Reynolds GM, Barber PC, Brown G.

Lab Invest. 1995 Jan;72(1):100-13.

PMID:
7837783
9.

Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer.

Singer S, Malz M, Herpel E, Warth A, Bissinger M, Keith M, Muley T, Meister M, Hoffmann H, Penzel R, Gdynia G, Ehemann V, Schnabel PA, Kuner R, Huber P, Schirmacher P, Breuhahn K.

Cancer Res. 2009 Mar 15;69(6):2234-43. doi: 10.1158/0008-5472.CAN-08-3338. Epub 2009 Mar 3.

10.

Aneugenic activity of Op18/stathmin is potentiated by the somatic Q18-->e mutation in leukemic cells.

Holmfeldt P, Brännström K, Stenmark S, Gullberg M.

Mol Biol Cell. 2006 Jul;17(7):2921-30. Epub 2006 Apr 19.

11.

The oncoprotein 18/stathmin family of microtubule destabilizers.

Cassimeris L.

Curr Opin Cell Biol. 2002 Feb;14(1):18-24. Review.

PMID:
11792540
12.

Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle.

Iancu C, Mistry SJ, Arkin S, Atweh GF.

Cancer Res. 2000 Jul 1;60(13):3537-41.

13.

Downregulation of stathmin expression is mediated directly by Egr1 and associated with p53 activity in lung cancer cell line A549.

Fang L, Min L, Lin Y, Ping G, Rui W, Ying Z, Xi W, Ting H, Li L, Ke D, Jihong R, Huizhong Z.

Cell Signal. 2010 Jan;22(1):166-73. doi: 10.1016/j.cellsig.2009.09.030. Epub 2009 Sep 25.

PMID:
19786090
14.

Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells.

Brattsand G, Roos G, Marklund U, Ueda H, Landberg G, Nånberg E, Sideras P, Gullberg M.

Leukemia. 1993 Apr;7(4):569-79.

PMID:
8464235
15.

Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression.

San-Marina S, Han Y, Liu J, Minden MD.

Biochim Biophys Acta. 2012 Nov-Dec;1819(11-12):1164-72. doi: 10.1016/j.bbagrm.2012.09.004. Epub 2012 Sep 19.

PMID:
23000483
16.

Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors.

Sadow PM, Rumilla KM, Erickson LA, Lloyd RV.

Endocr Pathol. 2008 Summer;19(2):97-103. doi: 10.1007/s12022-008-9028-0.

PMID:
18461287
17.
18.

Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresis.

Balasubramani M, Nakao C, Uechi GT, Cardamone J, Kamath K, Leslie KL, Balachandran R, Wilson L, Day BW, Jordan MA.

Mutat Res. 2011 Jun 17;722(2):154-64. doi: 10.1016/j.mrgentox.2010.08.019. Epub 2010 Sep 9.

19.

STMN1 overexpression correlates with biological behavior in human cutaneous squamous cell carcinoma.

Li X, Wang L, Li T, You B, Shan Y, Shi S, Qian L, Cao X.

Pathol Res Pract. 2015 Nov;211(11):816-23. doi: 10.1016/j.prp.2015.07.009. Epub 2015 Jul 16.

PMID:
26235036

Supplemental Content

Support Center